RecruitingNCT04102930
Clinical and Immunogenetic Characterization of Giant Cell Arteritis (GCA) and Polymyalgia Rheumatica (PMR)
Studying Giant cell arteritis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Leeds
- Principal Investigator
- Ann MorganUniversity of Leeds
- Enrollment
- 4500 enrolled
- Eligibility
- 50 years · All sexes
- Timeline
- 2005 – 2028
Study locations (30)
- Queen Elizabeth The Queen Mother Hospital, Canterbury, Kent, United Kingdom
- Whiston Hospital, Prescot, Merseyside, United Kingdom
- Nevill Hall Hospital, Aneurin Bevan University Health Board, Abergavenny, United Kingdom
- Stoke Mandeville Hospital, Buckinghamshire Healthcare NHS Trust, Aylesbury, United Kingdom
- Betsi Cadwaladr University Health Board, Bangor, United Kingdom
- Barnsley Hospital, Barnsley Hospital NHS Foundation Trust, Barnsley, United Kingdom
- Basildon University Hospital, Basildon and Thurrock University Hospitals NHS Foundation Trust, Basildon, United Kingdom
- Basingstoke and North Hampshire Hospital, Hampshire Hospitals NHS Foundation Trust, Basingstoke, United Kingdom
- Royal National Hospital for Rheumatic Diseases, Royal United Hospitals Bath NHS Foundation Trust, Bath, United Kingdom
- Birmingham Heartlands Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom
- Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom
- Bristol Royal Infirmary, University Hospitals Bristol NHS Foundation Trust, Bristol, United Kingdom
- Queen's Hospital, University Hospitals of Derby and Burton NHS Foundation Trust, Burton-on-Trent, United Kingdom
- West Suffolk Hospital, West Suffolk NHS Foundation Trust, Bury St Edmunds, United Kingdom
- Addenbrookes Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom
- +15 more locations on ClinicalTrials.gov
Collaborators
University of Oxford
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04102930 on ClinicalTrials.govOther trials for Giant cell arteritis
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07108387Tocilizumab Discontinuation Versus Dose Reduction for Patients With Well-Controlled Giant Cell ArteritisNational Institute of Allergy and Infectious Diseases (NIAID)
- RECRUITINGNCT07084480Giant Cell Arteritis - Ways to Precision MedicineWuerzburg University Hospital
- RECRUITINGNANCT07001059oPtic Nerve Sheath Evaluation in gianT Cell aRtheritis by UltraSoundHôpital NOVO
- RECRUITINGNCT06894602Association of Ultrasonographic Temporal Artery Lesions and Relapse in Patients With Giant Cell ArteritisUniversity Hospital, Brest
- RECRUITINGNCT05749094Optic Nerve Sheath Ultrasound in Giant Cell ArteritisCentre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal
- ACTIVE NOT RECRUITINGNCT05703763The Applanation Tonometry in GCA PilotCentre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal
- RECRUITINGPHASE2NCT06887062Dapagliflozin and Endothelin Receptor Antagonism in Large Vessel Vasculitis (DERAIL-LVV)University of Edinburgh
- RECRUITINGNCT06742671Performance of a Fast-track Pathway for Giant Cell Arteritis DiagnosisGroupe Hospitalier de la Rochelle Ré Aunis